Colitis: all 1,059 studies

Page 2 of 11. Open to participants first (124), then studies with results posted, then the rest; newest registration first within each.

• Combined Application of EEN in the Induction of Remission in PUCNot yet recruitingNCT04999241Phase 4
• Top Down Versus Step up in Pediatric Ulcerative ColitisRecruitingNCT04999228Phase 4
• Multi-interventional Program to Reduce Chronic Ileoanal Pouch Leaks in UCNot yet recruitingNCT04939025Not applicable
• Screening Donors, Fecal Microbiota Transplant Program in Ulcerative ColitisRecruitingNCT04926103Not applicable
• MS-20 on Patients With Ulcerative Colitis(UC)RecruitingNCT04908644Not applicable
• Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.RecruitingNCT04897282
• Mitochondrial DAMPs as Mechanistic Biomarkers of Mucosal Inflammation in Crohn's Disease and Ulcerative ColitisRecruitingNCT04760964
• Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative ColitisRecruitingNCT04743518Phase 4
• Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese PatientsRecruitingNCT04721873Phase 2
• Fertility and Pregnancy After Surgery IBD AuditRecruitingNCT04663971
• De-escalation of Anti-TNF Therapy in Inflammatory Bowel DiseaseEnrolling by invitationNCT04646187Phase 4
• A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating AdalimumabRecruitingNCT04183608Phase 4
• Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative ColitisRecruitingNCT04133194Phase 4
• Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic ColitisRecruitingNCT04043897Phase 2
• Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsRecruitingNCT04038619Phase 1
• QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative ColitisRecruitingNCT04030676Not applicable
• Is Diverting Loop Ileostomy Necessary in Completion Proctectomy With Ileal Pouch Anal- Anastomosis: A Multicentre, Randomized Study of the GETAID Chirurgie Group. IDEAL TrialRecruitingNCT03872271Not applicable
• Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerRecruitingNCT03819296Phase 1
• Fecal Microbiota Transplantation for Ulcerative ColitisRecruitingNCT03804931Phase 2/3
• Gut Microbiome in Inflammatory Bowel DiseaseRecruitingNCT03589183
• Autologous Stem Cell Transplant for Crohn's DiseaseRecruitingNCT03219359Phase 2
• Defined Fecal Microbiota Transplantation for Clostridium Difficile DiarrheaEnrolling by invitationNCT01868373Phase 1
• Standardized Fecal Microbiota Transplantation for Ulcerative ColitisRecruitingNCT01790061Phase 2/3
• Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.RecruitingNCT01731665
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)TerminatedNCT06137183Phase 2Results posted
• A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisCompletedNCT05796245Results posted
• A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in RemissionTerminatedNCT05479058Phase 3Results posted
• This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.CompletedNCT05082428Results posted
• Etrasimod Dose-Ranging Versus Placebo as Induction Therapy Study in Adult Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCompletedNCT05061446Phase 2Results posted
• A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative ColitisCompletedNCT04877990Phase 2Results posted
• A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)CompletedNCT04873700Results posted
• Comparative Effectiveness of Biologics or Small Molecule Therapies in Inflammatory Bowel Disease (IBD)CompletedNCT04852666Results posted
• A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's DiseaseCompletedNCT04804540Phase 4Results posted
• Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)CompletedNCT04706793Phase 3Results posted
• A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)CompletedNCT04700449Phase 2Results posted
• A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)TerminatedNCT04677179Phase 2Results posted
• A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT04613518Phase 2Results posted
• Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative ColitisCompletedNCT04596293Phase 2Results posted
• A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative ColitisCompletedNCT04577794Phase 2Results posted
• Second Line Induction Therapy and Healthy Diet for Patients With Ulcerative ColitisCompletedNCT04505410Phase 3Results posted
• Regulation of Mucosal Healing in Inflammatory Bowel DiseaseCompletedNCT04504136Not applicableResults posted
• Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, JordanCompletedNCT04223479Phase 2/3Results posted
• CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Colitis (LIBERTY-UC)CompletedNCT04205643Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Tilpisertib in Adults With Moderately to Severely Active Ulcerative ColitisTerminatedNCT04130919Phase 2Results posted
• Study of Efficacy, Safety, and Tolerability of LYS006, in Patients With Mild to Moderate Ulcerative ColitisTerminatedNCT04074590Phase 2Results posted
• Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving AsacolTerminatedNCT04032652Phase 2Results posted
• A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)CompletedNCT04004611Phase 2Results posted
• Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative ColitisCompletedNCT03998488Phase 2Results posted
• Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative ColitisCompletedNCT03996369Phase 3Results posted
• Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative ColitisCompletedNCT03945188Phase 3Results posted
• Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)TerminatedNCT03943550Phase 1Results posted
• Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT03934216Phase 2Results posted
• TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) StudyTerminatedNCT03920254Phase 2/3Results posted
• Safety, Tolerability, Efficacy and Dose-response of GSK2831781 in Ulcerative ColitisTerminatedNCT03893565Phase 2Results posted
• Infliximab Biosimilar "Pfizer" Drug Use Investigation (Crohn's Disease or Ulcerative Colitis)CompletedNCT03884439Results posted
• Efficacy and Safety of Oral BT-11 in Ulcerative ColitisCompletedNCT03861143Phase 2Results posted
• Efficacy and Safety of BBT-401-1S in Ulcerative ColitisTerminatedNCT03800420Phase 2Results posted
• A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative ColitisTerminatedNCT03759041Phase 2Results posted
• Efficacy & Safety of TD-1473 in Ulcerative ColitisTerminatedNCT03758443Phase 2/3Results posted
• A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior TherapyCompletedNCT03695185Phase 2Results posted
• A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.CompletedNCT03675477Phase 2Results posted
• A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT03653026Phase 3Results posted
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of UTTR1147A in Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseTerminatedNCT03650413Phase 2Results posted
• Xeljanz Special Investigation for Long-term Use in UC PatientsCompletedNCT03643211Results posted
• Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on TofacitinibTerminatedNCT03591770Phase 4Results posted
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)CompletedNCT03558152Phase 2Results posted
• A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean ParticipantsCompletedNCT03535649Results posted
• A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's DiseaseTerminatedNCT03478956Phase 1Results posted
• Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile InfectionCompletedNCT03462459Phase 2Results posted
• A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative ColitisCompletedNCT03398148Phase 2/3Results posted
• Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel DiseaseCompletedNCT03397108Results posted
• Study Evaluating the Long-term Safety and Efficacy of ABX464 in Active Ulcerative ColitisCompletedNCT03368118Phase 2Results posted
• Phase 2 Dose-finding IMU-838 for Ulcerative ColitisTerminatedNCT03341962Phase 2Results posted
• Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UCTerminatedNCT03298022Phase 2Results posted
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT03290781Phase 3Results posted
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)CompletedNCT03283085Phase 3Results posted
• A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable RemissionTerminatedNCT03281304Phase 4Results posted
• Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.TerminatedNCT03269695Phase 2Results posted
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisTerminatedNCT03259334Phase 3Results posted
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisTerminatedNCT03259308Phase 3Results posted
• The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative ColitisCompletedNCT03178669Phase 2Results posted
• Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative ColitisTerminatedNCT03169894Phase 1Results posted
• Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)CompletedNCT03138655Phase 2Results posted
• Study of the Golimumab Exposure-Response Relationship Using Serum Trough LevelsCompletedNCT03124121Phase 4Results posted
• ABX464 in Subjects With Moderate to Severe Active Ulcerative ColitisCompletedNCT03093259Phase 2Results posted
• Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative ColitisCompletedNCT03029143Phase 4Results posted
• Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative ColitisCompletedNCT03018925Results posted
• Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative ColitisCompletedNCT02958865Phase 2Results posted
• Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UCTerminatedNCT02954159Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative ColitisCompletedNCT02914522Phase 3Results posted
• GSK2982772 Study in Subjects With Ulcerative ColitisCompletedNCT02903966Phase 2Results posted
• A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative ColitisCompletedNCT02883452Phase 1Results posted
• Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.CompletedNCT02840721Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)CompletedNCT02819635Phase 2/3Results posted
• Efficacy and Safety Study of GED-0507-34-Levo for Treatment of UCTerminatedNCT02808390Phase 2Results posted
• Open-label Extension Study to Assess Safety and Tolerability of LYC-30937-EC in Subjects With Active Ulcerative ColitisTerminatedNCT02764229Phase 2Results posted
• An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative ColitisCompletedNCT02762500Phase 2Results posted
• Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)CompletedNCT02750800Results posted
• Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's DiseaseTerminatedNCT02743806Phase 4Results posted
• Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative ColitisCompletedNCT02647866Phase 2Results posted

← Colitis overview